Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Balziva

Last reviewed on RxList: 7/16/2019
Balziva Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Last reviewed on RxList 7/16/2019

Balziva (norethindrone and ethinyl estradiol tablets) is an oral contraceptive indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Balziva is available in generic form. Common side effects of Balziva include:

Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. Women who use oral contraceptives are strongly advised not to smoke.

The Balziva 28-pill pack has 21 “active” light peach pills (with hormones) to take for 3 weeks, followed by 1 week of reminder white pills (without hormones). Take one pill at the same time every day until the pack is empty. On the 28-day regimen, start the next pack the day after the last inactive tablet and not wait any days between packs. Balziva may interact with:

Tell your doctor all medications and supplements you use. Balziva is not recommended for use during pregnancy. Small amounts of oral contraceptives such as Balziva pass into breast milk and may interfere with lactation by decreasing the quantity and quality of breast milk. Nursing mothers are advised to use other forms of contraception until the child is weaned. Consult your doctor before breastfeeding.

Our Balziva (norethindrone and ethinyl estradiol tablets) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

QUESTION

Which of the following are methods for contraception? See Answer
Balziva Professional Information

SIDE EFFECTS

An increased risk of the following serious adverse reactions has been associated with the use of oral contraceptives (see WARNINGS section):

There is evidence of an association between the following conditions and the use of oral contraceptives, although additional confirmatory studies are needed:

  • Mesenteric thrombosis
  • Retinal thrombosis

The following adverse reactions have been reported in patients receiving oral contraceptives and are believed to be drug-related:

  • Nausea
  • Vomiting
  • Gastrointestinal symptoms (such as abdominal cramps and bloating)
  • Breakthrough bleeding
  • Spotting
  • Change in menstrual flow
  • Amenorrhea
  • Temporary infertility after discontinuation of treatment
  • Edema
  • Melasma which may persist
  • Breast changes: tenderness, enlargement, and secretion
  • Change in weight (increase or decrease)
  • Change in cervical ectropion and secretion
  • Possible diminution in lactation when given immediately postpartum
  • Cholestatic jaundice
  • Migraine
  • Rash (allergic)
  • Mental depression
  • Reduced tolerance to carbohydrates
  • Vaginal candidiasis
  • Change in corneal curvature (steepening)
  • Intolerance to contact lenses

The following adverse reactions have been reported in users of oral contraceptives, and the association has been neither confirmed nor refuted:

Read the entire FDA prescribing information for Balziva (Ethinyl Estradiol and Norethindrone Tablets)

SLIDESHOW

Choosing Your Birth Control Method See Slideshow
Related Resources for Balziva

© Balziva Patient Information is supplied by Cerner Multum, Inc. and Balziva Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors

CONTINUE SCROLLING FOR RELATED SLIDESHOW